Cancer Evolution: Can Death Reveal the Logic of Life?
When a theory of biology asks us to see death
as creative, it is no longer describing reality.
It is inverting it.
Cancer Evolution: the Dialectic of Death
by John Wise, PhD
I hate cancer. Its mere mention makes my blood boil. Until writing this article for CEH, I had never fully understood why. I have not lost someone close to me because of its scourge, nor have I suffered its ravages myself. Yet my response has always been visceral, almost moral in its intensity. Cancer’s malignance feels personal, not because of what it has taken from me, but because of what it pretends to be.
This issue crystallized for me as I read a Science Daily article with the confident title: “Scientists just cracked the hidden rules of cancer evolution,” January 26, 2026. It comes from a press release from the Moffitt Cancer Center in Florida:
Moffitt Study Develops New Tool to Predict How Cancer Evolves (Moffitt Cancer Center, 22 January 2026). At first glance, the headline seems harmless, even promising. But once you slow down and examine what the researchers actually discovered, a deeper problem announces itself before the article begins.
The article summarizes new research published in Nature Communications, “ALFA-K: Local adaptive mapping of karyotype fitness landscapes,” 27 December 2025, describing a computational framework called ALFA-K. The method tracks how cancer cells gain and lose whole chromosomes over time and maps which combinations allow tumors to grow, adapt, and resist treatment. By following thousands of individual cells, the researchers claim they can forecast how tumors will change and even anticipate dangerous transitions before they occur.
The Science Daily article’s summary captures the claim succinctly:
Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that help tumors grow, adapt, and survive treatment.
That framing sounds like progress. But notice what has been conceded. Cancer is no longer said to evolve through blind chance governed by natural selection. It follows “hidden rules.” Its future states can be anticipated. That is not a small adjustment to evolutionary theory. It is a quiet surrender of its core premise.
The article makes this explicit:
The results challenge the idea that cancer evolution is driven by chance alone. Instead, the study shows that tumors follow measurable patterns shaped by chromosome makeup, evolutionary pressures, and treatment-related stress.
Once chance (random mutation) is removed from the driver’s seat and replaced with rules and patterns, the word evolution begins to slip, losing traction. What exactly is evolving here?
To understand the claim, we need one technical definition. A karyotype is a cell’s full chromosome inventory, the number of copies of each chromosome it carries. Cancer cells often gain or lose entire chromosomes, a condition called aneuploidy (not possessing the correct number of chromosomes – for humans: 46, or 23 pairs). These are not subtle genetic tweaks. They are massive disruptions affecting hundreds or thousands of genes at once.
In the context of cancer’s “evolution,” the article celebrates this disruption as a feature rather than a flaw:
These changes allow cancer cells to make large evolutionary jumps rather than small adjustments.
But this is precisely where language outruns biology. Whole-chromosome gains and losses do not create new genetic information. They do not invent new functions. They reshuffle gene dosage across an already existing genome. That is not creative novelty. It is pathological redistribution.
What cancer “gains” comes from loosening the constraints that once enforced cooperation within the organism. The whole is being sacrificed to a part. Cancer cells survive by abandoning the very rules that make multicellular life possible. That may confer a short-term advantage for the cancer cells, but it is advantage by disintegration, by anti-design.
The evolutionary bravado appears in its starkest form when the article simply declares, without qualification: “Cancer evolves.” Full stop. That sentence carries enormous cultural weight. I grew up with its cousin ringing in my ears: “Evolution is a fact.”
The hubris in that phrase is the argument.
But the data, as we are finding on every front, tell a different story.
The ALFA-K framework reveals that cancer progression depends heavily on thresholds. One of the most telling claims in the article is that whole-genome doubling becomes advantageous only after a certain buffering point is reached. Below that threshold, it is harmful. Above it, it can be tolerated.
Thresholds matter. They imply pre-existing structure, measured tolerance. They signal that fitness is not intrinsic to a mutation but conditional on the system’s state. This is not blind exploration. It is a constrained system revealing where it can break without immediately collapsing.
That is why the authors can say, without irony, that their method may help doctors detect when a tumor is “approaching a dangerous evolutionary transition.” If transitions can be anticipated, mapped, and steered, then “evolution” has ceased to be an explanation. It has become a label for movement within a pre-given architecture.
Cancer/Evolution
Cancer is often described as life gone wrong. But what unsettles me most is how often it is described as life unbounded. It grows, adapts, survives. In the language of our article:
“Cancer evolves”
It thrives. It succeeds.
Yet cancer succeeds only by consuming the life that gives it both context and meaning, that subsidizes its pathological “success.” It wins locally by destroying universally.
Cancer is a runaway pathological process that defies natural boundaries.
That should sound familiar.
There is a timeless warning about calling evil good and good evil. Cancer biology now offers a biological parable of that inversion. Death, in evolutionary terms, becomes the engine of life. Death and destruction have become creative. Breakdown is innovation. Negation drives progress.
The ALFA-K study is impressive science. It maps constraints with real precision. But the more predictable cancer becomes, the less sense it makes to call its behavior “evolution” in any traditional sense. What we are really seeing is not life inventing itself, but life revealing the rules it was always living under, rules that cancer “survives” only by violating.
“Evolution by natural selection.” Words matter. When pathology is mistaken for progress, clarity is in danger. And when death is treated as creative, as life-giving, something far deeper than biology has gone wrong. Thus, “evolution” is not a logic of life – biology – at all.
It is Life’s contradiction. Anti-logic.
I now understand why I hate cancer. It survives by pretending to be life. And when a theory of biology asks us to see death, breakdown, and negation as creative, it is no longer describing reality.
It is inverting it.
John Wise received his PhD in philosophy from the University of CA, Irvine in 2004. His dissertation was titled Sartre’s Phenomenological Ontology and the German Idealist Tradition. His area of specialization is 19th to early 20th century continental philosophy.
He tells the story of his 25-year odyssey from atheism to Christianity in the book, Through the Looking Glass: The Imploding of an Atheist Professor’s Worldview (available on Amazon). Since his return to Christ, his research interests include developing a Christian (YEC) philosophy of science and the integration of all human knowledge with God’s word.
He has taught philosophy for the University of CA, Irvine, East Stroudsburg University of PA, Grand Canyon University, American Intercontinental University, and Ashford University. He currently teaches online for the University of Arizona, Global Campus, and is a member of the Heterodox Academy. He and his wife Jenny are known online as The Christian Atheist with a podcast of that name, in addition to a YouTube channel: John and Jenny Wise.